Green Cross Health Limited (NZE:GXH)
New Zealand
· Delayed Price · Currency is NZD 0.8500
+0.0200 (2.41%)
Jun 27, 2025, 4:29 PM NZST
Green Cross Health Income Statement
Financials in millions NZD. Fiscal year is April - March.
Millions NZD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| 523.76 | 503.92 | 493.61 | 478.09 | 570.4 | Upgrade
| |
Revenue Growth (YoY) | 3.94% | 2.09% | 3.25% | -16.18% | 0.33% | Upgrade
|
Cost of Revenue | 464.14 | 447.76 | 435.4 | 407.23 | 510.86 | Upgrade
|
Gross Profit | 59.62 | 56.16 | 58.21 | 70.86 | 59.54 | Upgrade
|
Selling, General & Admin | 3.13 | 4.32 | 3 | 0.39 | 2.21 | Upgrade
|
Operating Expenses | 22.48 | 24.84 | 25.08 | 23.37 | 25.61 | Upgrade
|
Operating Income | 37.14 | 31.31 | 33.13 | 47.49 | 33.94 | Upgrade
|
Interest Expense | -10.48 | -10.27 | -7.8 | -6.18 | -6.26 | Upgrade
|
Interest & Investment Income | 0.59 | 0.9 | 0.58 | 0.08 | 0.08 | Upgrade
|
Earnings From Equity Investments | 1.59 | 1.2 | 1.32 | 1.89 | 1.41 | Upgrade
|
EBT Excluding Unusual Items | 28.84 | 23.14 | 27.23 | 43.28 | 29.17 | Upgrade
|
Asset Writedown | -0.01 | -0.72 | -0.13 | -0.84 | -0.24 | Upgrade
|
Pretax Income | 28.84 | 22.42 | 27.1 | 42.44 | 28.93 | Upgrade
|
Income Tax Expense | 8.09 | 6.59 | 6.8 | 13.02 | 7.89 | Upgrade
|
Earnings From Continuing Operations | 20.74 | 15.83 | 20.3 | 29.42 | 21.04 | Upgrade
|
Earnings From Discontinued Operations | - | -0.28 | 30.25 | 3.68 | - | Upgrade
|
Net Income to Company | 20.74 | 15.55 | 50.55 | 33.09 | 21.04 | Upgrade
|
Minority Interest in Earnings | -4.77 | -3.8 | -5.32 | -9.19 | -4.28 | Upgrade
|
Net Income | 15.98 | 11.76 | 45.23 | 23.9 | 16.75 | Upgrade
|
Net Income to Common | 15.98 | 11.76 | 45.23 | 23.9 | 16.75 | Upgrade
|
Net Income Growth | 35.88% | -74.01% | 89.25% | 42.68% | 24.18% | Upgrade
|
Shares Outstanding (Basic) | 144 | 143 | 143 | 143 | 143 | Upgrade
|
Shares Outstanding (Diluted) | 144 | 144 | 144 | 144 | 143 | Upgrade
|
Shares Change (YoY) | 0.10% | -0.04% | 0.11% | 0.24% | -0.06% | Upgrade
|
EPS (Basic) | 0.11 | 0.08 | 0.32 | 0.17 | 0.12 | Upgrade
|
EPS (Diluted) | 0.11 | 0.08 | 0.31 | 0.17 | 0.12 | Upgrade
|
EPS Growth | 35.73% | -74.00% | 89.07% | 42.33% | 24.23% | Upgrade
|
Free Cash Flow | 46.8 | 38.56 | 40.2 | 61.74 | 65.97 | Upgrade
|
Free Cash Flow Per Share | 0.33 | 0.27 | 0.28 | 0.43 | 0.46 | Upgrade
|
Dividend Per Share | 0.052 | 0.045 | 0.070 | 0.065 | - | Upgrade
|
Dividend Growth | 16.67% | -35.71% | 7.69% | - | - | Upgrade
|
Gross Margin | 11.38% | 11.14% | 11.79% | 14.82% | 10.44% | Upgrade
|
Operating Margin | 7.09% | 6.21% | 6.71% | 9.93% | 5.95% | Upgrade
|
Profit Margin | 3.05% | 2.33% | 9.16% | 5.00% | 2.94% | Upgrade
|
Free Cash Flow Margin | 8.94% | 7.65% | 8.14% | 12.91% | 11.56% | Upgrade
|
EBITDA | 41.91 | 37.57 | 39.43 | 53.68 | 39.86 | Upgrade
|
EBITDA Margin | 8.00% | 7.46% | 7.99% | 11.23% | 6.99% | Upgrade
|
D&A For EBITDA | 4.77 | 6.25 | 6.3 | 6.18 | 5.92 | Upgrade
|
EBIT | 37.14 | 31.31 | 33.13 | 47.49 | 33.94 | Upgrade
|
EBIT Margin | 7.09% | 6.21% | 6.71% | 9.93% | 5.95% | Upgrade
|
Effective Tax Rate | 28.07% | 29.40% | 25.11% | 30.68% | 27.28% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.